Bausch Health Companies | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Amgen USD 6.21B 330M 2025-03
ANI Pharmaceuticals USD 403.68M 2.27M 2024-12
Aurora Cannabis CAD 572.92M 29.75M 2024-12
Bausch Health Companies USD -1183000000 861M 2025-03
Biogen USD 16.98B 262.7M 2025-03
Bristol-Myers Squibb USD 17.39B 1.05B 2025-03
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 679.59M 40.75M 2024-12
Danaher USD 50.85B 1.31B 2025-03
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Perrigo USD 4.32B 246.6M 2024-12
Prestige Brands USD 1.79B 56.67M 2024-12
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12
Zoetis USD 4.77B 464M 2024-12



Bausch Health Companies Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.